울트라4™

Hormonal changes in women significantly affect not only reproductive health but also mood and overall condition. However, precise tracking at home has been difficult. Existing ovulation tests only measure LH, and detailed hormone patterns require a hospital visit and blood tests.

This can lead to problems such as failure to recognize PCOS (Polycystic Ovary Syndrome) or PMDD (Premenstrual Dysphoric Disorder) early on, or difficulty in frequently monitoring the effects of hormone therapy.

Ultra4 uses fluorescence immunoassay technology to simultaneously and quantitatively analyze four hormones in urine: follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen metabolite (E3G), and progesterone metabolite (PdG). With 7x higher accuracy, it captures even subtle hormonal changes, detecting early ovulation signs missed by existing home kits. AI-based 4D Ovulation Profiling™ and Hormone Ratio Scan™ derive ovarian reserve and hormone imbalances.

The data is visualized in the app, allowing users to understand PMS symptoms or energy fluctuations in relation to hormonal changes, and generates reports for use during doctor consultations. In short, it is a solution to "obtain lab-quality hormone panels at home in real-time."

The main users are women of childbearing age, couples preparing for pregnancy, and women in the menopausal transition, sold via B2C. A B2B2C model is also possible, where obstetrics and gynecology/reproductive medicine clinics recommend or purchase it for patient management.

Already sold in North America and Europe, it is growing in the global wellness device market. It can be further expanded into a multi-biomarker platform for male hormones or stress hormones, evolving into a comprehensive home health lab.

However, to be used for diagnostic purposes requiring medical device approval, regulatory approvals are additionally required in each country.

It was praised as a game-changer in women's health management. Like the evaluation that it "revealed hidden patterns of 51% of the population," it is expected to be a tool that contributes to improving the quality of life for women.

Superior to existing products in accuracy and convenience, user satisfaction is high and it is spreading by word of mouth in the community (Mira's previous works also have good reviews). However, the cost of consumables (test strips) may be a burden in the long term, and there is a challenge in how to link the data with medical care.

Overall, it is a highly reliable solution with market validation already in progress.